Vertex Pharmaceuticals Shares Outstanding 2006-2018 | VRTX

Vertex Pharmaceuticals shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Vertex Pharmaceuticals shares outstanding for the quarter ending September 30, 2018 were 0.260B, a 3.8% increase year-over-year.
  • Vertex Pharmaceuticals 2017 shares outstanding were 0.253B, a 3.49% increase from 2016.
  • Vertex Pharmaceuticals 2016 shares outstanding were 0.245B, a 1.4% increase from 2015.
  • Vertex Pharmaceuticals 2015 shares outstanding were 0.241B, a 2.55% increase from 2014.
Vertex Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2017 253
2016 245
2015 241
2014 235
2013 225
2012 215
2011 209
2010 200
2009 173
2008 141
2007 129
2006 113
2005 89
Vertex Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 260
Q2 2018 259
Q1 2018 259
Q4 2017 253
Q3 2017 250
Q2 2017 252
Q1 2017 249
Q4 2016 245
Q3 2016 245
Q2 2016 244
Q1 2016 244
Q4 2015 241
Q3 2015 242
Q2 2015 241
Q1 2015 239
Q4 2014 235
Q3 2014 236
Q2 2014 234
Q1 2014 233
Q4 2013 225
Q3 2013 231
Q2 2013 222
Q1 2013 215
Q4 2012 215
Q3 2012 214
Q2 2012 211
Q1 2012 219
Q4 2011 209
Q3 2011 219
Q2 2011 204
Q1 2011 202
Q4 2010 200
Q3 2010 201
Q2 2010 200
Q1 2010 199
Q4 2009 173
Q3 2009 179
Q2 2009 173
Q1 2009 156
Q4 2008 141
Q3 2008 140
Q2 2008 139
Q1 2008 134
Q4 2007 129
Q3 2007 130
Q2 2007 129
Q1 2007 126
Q4 2006 113
Q3 2006 113
Q2 2006 109
Q1 2006 107
Q4 2005 89
Q3 2005 95
Q2 2005 82
Q1 2005 79
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $43.524B $2.489B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.059B 13.80
Gilead Sciences (GILD) United States $91.744B 11.05
Biogen (BIIB) United States $64.289B 13.02
Celgene (CELG) United States $49.115B 9.53
Illumina (ILMN) United States $45.743B 53.28
Regeneron Pharmaceuticals (REGN) United States $36.966B 18.75
Alexion Pharmaceuticals (ALXN) United States $26.441B 18.09
BioMarin Pharmaceutical (BMRN) United States $16.652B 0.00
Incyte (INCY) United States $13.562B 374.88
Seattle Genetics (SGEN) United States $8.782B 0.00
Exact Sciences (EXAS) United States $8.531B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
QIAGEN (QGEN) Netherlands $7.959B 25.45
Sarepta Therapeutics (SRPT) United States $7.803B 0.00
Alnylam Pharmaceuticals (ALNY) United States $6.800B 0.00
Bluebird Bio (BLUE) United States $6.579B 0.00
BeiGene (BGNE) Cayman Islands $6.166B 0.00
Bio-Techne Corp (TECH) United States $6.117B 41.32
Galapagos (GLPG) Belgium $5.266B 0.00
Alkermes (ALKS) Ireland $5.263B 3387.00
Exelixis (EXEL) United States $4.978B 14.11
Amarin (AMRN) Ireland $4.496B 0.00
Horizon Pharma Public (HZNP) Ireland $3.663B 15.07
Immunomedics (IMMU) United States $3.576B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.569B 0.00
Emergent Biosolutions (EBS) United States $3.400B 28.64
Allogene Therapeutics (ALLO) United States $3.192B 0.00
Ligand Pharmaceuticals (LGND) United States $3.155B 24.14
Guardant Health (GH) United States $3.148B 0.00
Array BioPharma (ARRY) United States $3.134B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.987B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.974B 0.00
Repligen (RGEN) United States $2.868B 89.57
Genomic Health (GHDX) United States $2.814B 95.00
Blueprint Medicines (BPMC) United States $2.642B 0.00
Ascendis Pharma (ASND) Denmark $2.564B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.471B 0.00
China Biologic Products (CBPO) China $2.418B 17.22
Allakos (ALLK) United States $2.399B 0.00
Acceleron Pharma (XLRN) United States $2.372B 0.00
Akcea Therapeutics (AKCA) United States $2.333B 0.00
MyoKardia (MYOK) United States $2.279B 0.00
REGENXBIO (RGNX) United States $2.247B 30.14
Myriad Genetics (MYGN) United States $2.242B 22.22
Halozyme Therapeutics (HALO) United States $2.238B 49.94
ACADIA Pharmaceuticals (ACAD) United States $2.228B 0.00
Amicus Therapeutics (FOLD) United States $2.041B 0.00
Global Blood Therapeutics (GBT) United States $1.973B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.893B 0.00
AnaptysBio (ANAB) United States $1.870B 0.00
Reata Pharmaceuticals (RETA) United States $1.823B 0.00
Medicines (MDCO) United States $1.684B 0.00
Aimmune Therapeutics (AIMT) United States $1.666B 0.00
Arena Pharmaceuticals (ARNA) United States $1.662B 0.00
Denali Therapeutics (DNLI) United States $1.640B 0.00
Innoviva (INVA) United States $1.636B 9.25
G1 THERAPEUTICS (GTHX) United States $1.618B 0.00
Spark Therapeutics (ONCE) United States $1.611B 0.00
Atara Biotherapeutics (ATRA) United States $1.587B 0.00
Cambrex (CBM) United States $1.580B 11.80
NeoGenomics (NEO) United States $1.535B 126.92
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.532B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.481B 0.00
Rubius Therapeutics (RUBY) United States $1.390B 0.00
Editas Medicine (EDIT) United States $1.386B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.356B 0.00
IMMURON LTD (IMRN) Australia $1.294B 0.00
Myovant Sciences (MYOV) United Kingdom $1.277B 0.00
Insmed (INSM) United States $1.233B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.223B 0.00
Mirati Therapeutics (MRTX) United States $1.210B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.184B 94.04
WAVE Life Sciences (WVE) Singapore $1.151B 0.00
Solid Biosciences (SLDB) United States $1.132B 0.00
Sangamo Therapeutics (SGMO) United States $1.103B 0.00
Cellectis (CLLS) France $1.071B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.004B 0.00
Audentes Therapeutics (BOLD) United States $1.003B 0.00
Retrophin (RTRX) United States $0.999B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.984B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.979B 0.00
Intra-Cellular Therapies (ITCI) United States $0.947B 0.00
DBV Technologies (DBVT) France $0.943B 0.00
Acorda Therapeutics (ACOR) United States $0.918B 11.63
Alder BioPharmaceuticals (ALDR) United States $0.901B 0.00
UniQure (QURE) Netherlands $0.892B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.891B 0.00
Lion Biotechnologies (IOVA) United States $0.877B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.860B 0.00
Apellis Pharmaceuticals (APLS) United States $0.856B 0.00
Aptinyx (APTX) United States $0.854B 0.00
Fate Therapeutics (FATE) United States $0.844B 0.00
Puma Biotechnology (PBYI) United States $0.841B 0.00
Viking Therapeutics (VKTX) United States $0.824B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.815B 0.00
Clovis Oncology (CLVS) United States $0.804B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.804B 0.00
Revance Therapeutics (RVNC) United States $0.803B 0.00
Intellia Therapeutics (NTLA) United States $0.793B 0.00
Athenex (ATNX) United States $0.779B 0.00
Coherus BioSciences (CHRS) United States $0.758B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
Heska (HSKA) United States $0.742B 60.72
Dynavax Technologies (DVAX) United States $0.739B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.723B 0.00
InflaRx (IFRX) Germany $0.720B 0.00
AVROBIO (AVRO) United States $0.717B 0.00
Vericel (VCEL) United States $0.713B 0.00
TWIST BIOSCIENC (TWST) United States $0.649B 0.00
Novavax (NVAX) United States $0.647B 0.00
UROGEN PHARMA (URGN) Israel $0.646B 0.00
CytomX Therapeutics (CTMX) United States $0.642B 0.00
ANI Pharmaceuticals (ANIP) United States $0.612B 11.73
Gritstone Oncology (GRTS) United States $0.601B 0.00
Epizyme (EPZM) United States $0.600B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.596B 0.00
AC Immune SA (ACIU) Switzerland $0.588B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.587B 0.00
Principia Biopharma (PRNB) United States $0.575B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.567B 0.00
Senesco Technologies (ELOX) United States $0.561B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.560B 0.00
Scholar Rock Holding (SRRK) United States $0.556B 0.00
Arvinas (ARVN) United States $0.549B 0.00
UNITY Biotechnology (UBX) $0.531B 0.00
ObsEva SA (OBSV) Switzerland $0.514B 0.00
Eidos Therapeutics (EIDX) United States $0.510B 0.00
Anika Therapeutics (ANIK) United States $0.509B 21.07
Arcus Biosciences (RCUS) United States $0.495B 0.00
Mesoblast (MESO) Australia $0.480B 0.00
Kezar Life Sciences (KZR) United States $0.478B 0.00
BeyondSpring (BYSI) United States $0.464B 0.00
Inovio Pharmaceuticals (INO) United States $0.461B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.460B 0.00
Prothena (PRTA) Ireland $0.456B 0.00
Kura Oncology (KURA) United States $0.441B 0.00
Sorrento Therapeutics (SRNE) United States $0.435B 71.20
Replimune (REPL) United States $0.432B 0.00
Sinovac Biotech (SVA) China $0.429B 0.00
MediciNova (MNOV) United States $0.426B 0.00
Kindred Biosciences (KIN) United States $0.424B 0.00
PDL BioPharma (PDLI) United States $0.422B 6.88
Zymeworks (ZYME) Canada $0.417B 0.00
Five Prime Therapeutics (FPRX) United States $0.399B 0.00
RA PHARMCTL INC (RARX) United States $0.397B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.384B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.374B 0.00
Zealand Pharma (ZEAL) Denmark $0.374B 0.00
Verastem (VSTM) United States $0.373B 0.00
Stemline Therapeutics (STML) United States $0.372B 0.00
Osiris Therapeutics (OSIR) United States $0.369B 0.00
Abeona Therapeutics (ABEO) United States $0.368B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.366B 0.00
Cytokineticsorporated (CYTK) United States $0.356B 0.00
MeiraGTx Holdings (MGTX) United States $0.344B 0.00
Seres Therapeutics (MCRB) United States $0.331B 0.00
Cellular Biomedicine (CBMG) United States $0.324B 0.00
Merus (MRUS) Netherlands $0.315B 0.00
ResTORbio (TORC) United States $0.310B 0.00
LogicBio Therapeutics (LOGC) United States $0.305B 0.00
Sutro Biopharma (STRO) United States $0.304B 0.00
Liquidia Technologies (LQDA) United States $0.299B 0.00
Albireo Pharma (ALBO) United States $0.299B 0.00
Kodiak Sciences (KOD) United States $0.298B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.297B 0.00
Krystal Biotech (KRYS) United States $0.295B 0.00
Geron (GERN) United States $0.291B 0.00
MannKind (MNKD) United States $0.290B 0.00
Kadmon Holdings (KDMN) United States $0.287B 0.00
Celcuity (CELC) United States $0.284B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.284B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.265B 0.00
Athersys (ATHX) United States $0.265B 0.00
Arbutus Biopharma (ABUS) Canada $0.265B 0.00
Syros Pharmaceuticals (SYRS) United States $0.262B 0.00
Equillium (EQ) United States $0.260B 0.00
BioDelivery Sciences (BDSI) United States $0.256B 0.00
Aduro Biotech (ADRO) United States $0.254B 0.00
Evelo Biosciences (EVLO) United States $0.246B 0.00
Strongbridge Biopharma (SBBP) United States $0.244B 0.00
TOCAGEN INC (TOCA) United States $0.243B 0.00
Agenus (AGEN) United States $0.239B 0.00
Axovant Sciences (AXON) United Kingdom $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.237B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.234B 0.00
Unum Therapeutics (UMRX) United States $0.234B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.233B 0.00
Proteostasis Therapeutics (PTI) United States $0.231B 0.00
Adverum Biotechnologies (ADVM) United States $0.228B 0.00
Magenta Therapeutics (MGTA) United States $0.228B 0.00
Urovant Sciences (UROV) United States $0.222B 0.00
Kala Pharmaceuticals (KALA) United States $0.222B 0.00
BioTime (BTX) United States $0.221B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.220B 0.00
Kamada (KMDA) Israel $0.219B 20.15
Corvus Pharmaceuticals (CRVS) United States $0.212B 0.00
Idera Pharmaceuticals (IDRA) United States $0.207B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.205B 0.00
Protagonist Therapeutics (PTGX) United States $0.202B 0.00
Synlogic (SYBX) United States $0.195B 0.00
Intec Pharma (NTEC) Israel $0.194B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.189B 0.00
ChromaDex (CDXC) United States $0.188B 0.00
NantKwest (NK) United States $0.188B 0.00
Allena Pharmaceuticals (ALNA) United States $0.174B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.172B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.170B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.165B 20.30
Compugen (CGEN) Israel $0.164B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.162B 0.00
Cerecor (CERC) United States $0.157B 0.00
Cohbar (CWBR) United States $0.156B 0.00
Menlo Therapeutics (MNLO) United States $0.156B 0.00
Spero Therapeutics (SPRO) United States $0.154B 0.00
Pfenex (PFNX) United States $0.153B 0.00
Enzo Biochem (ENZ) United States $0.151B 0.00
PSivida (EYPT) United States $0.151B 0.00
Constellation Pharmaceuticals (CNST) United States $0.148B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
XBiotech (XBIT) United States $0.143B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.141B 0.00
Mersana Therapeutics (MRSN) United States $0.140B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.135B 0.00
Eleven Biotherapeutics (SESN) United States $0.131B 0.00
Organovo Holdings (ONVO) United States $0.130B 0.00
Applied Genetic Technologies (AGTC) United States $0.130B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.129B 0.00
OVID THERAPEUTC (OVID) United States $0.127B 0.00
Selecta Biosciences (SELB) United States $0.127B 0.00
Catalyst Biosciences (CBIO) United States $0.125B 0.00
VBI Vaccines (VBIV) United States $0.123B 0.00
Cue Biopharma (CUE) United States $0.122B 0.00
Mustang Bio (MBIO) United States $0.120B 0.00
Signal Genetics (MGEN) United States $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
XOMA (XOMA) United States $0.111B 0.00
Anavex Life Sciences (AVXL) United States $0.111B 0.00
CorMedix Inc (CRMD) United States $0.111B 0.00
Motif Bio Plc (MTFB) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.108B 0.00
Provention Bio (PRVB) United States $0.102B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Chiasma (CHMA) United States $0.097B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Orgenesis (ORGS) United States $0.091B 0.00
Monster Digital (INNT) United States $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
BioXcel Therapeutics (BTAI) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.086B 0.00
Ophthotech (OPHT) United States $0.084B 0.00
VolitionRX (VNRX) Singapore $0.081B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.081B 90.00
Cel-Sci (CVM) United States $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.076B 0.00
Aptose Biosciences (APTO) Canada $0.076B 0.00
Vaccinex (VCNX) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Aptevo Therapeutics (APVO) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
Evogene (EVGN) Israel $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
ITUS (ANIX) United States $0.069B 0.00
Asterias Biotherapeutics (AST) United States $0.069B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Fortress Biotech (FBIO) United States $0.063B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.061B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Sophiris Bio (SPHS) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
Bellerophon Therapeutics (BLPH) United States $0.058B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.058B 9.38
Oncobiologics (ONS) United States $0.058B 0.00
Leap Therapeutics (LPTX) United States $0.057B 0.00
Trevena (TRVN) United States $0.055B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
OncoSec Medical (ONCS) United States $0.050B 0.00
Curis (CRIS) United States $0.049B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.047B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
TRACON Pharmaceuticals (TCON) United States $0.042B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.042B 0.00
Oncolytics Biotech (ONCY) Canada $0.041B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
AEterna Zentaris (AEZS) United States $0.039B 7.44
Versartis (ARAV) United States $0.039B 6.29
AquaBounty Technologies (AQB) United States $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
Galena Biopharma (SLS) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.037B 0.00
VIVUS (VVUS) United States $0.035B 0.00
GTx (GTXI) United States $0.035B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
Aileron Therapeutics (ALRN) United States $0.032B 0.00
Proteon Therapeutics (PRTO) United States $0.032B 0.00
Therapix Biosciences (TRPX) Israel $0.029B 10.61
Vical (VICL) United States $0.028B 0.00
Advaxis (ADXS) United States $0.027B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
OvaScience (OVAS) United States $0.025B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
Cellect Biotechnology (APOP) Israel $0.024B 0.00
CytRx (CYTR) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Pulmatrix (PULM) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Arsanis (ASNS) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Histogenics (HSGX) United States $0.013B 0.00
Oragenics (OGEN) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.000B 0.00